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ABSTRACT 
Introduction: Tuberculosis is a serious public health problem in the developing countries. Assessment of 
tuberculosis treatment outcomes and its risk factors in directly observed treatment short course are among the 
major indicators of the performance of a national TB control program. Therefore; this study was undertaken to 
assess tuberculosis treatment outcome and its’ associated factors among patients treated under Directly Observed 
Treatment Short Course in health facilities at Adama Town, Central Oromia, Ethiopia from March 1st 2016 G.C 
to December 31/2016 G.C. Method: A cross sectional study was conducted in seventeen health facilities which 
initiated treatment and provided DOTs service at Adama Town. The data was collected using structured 
questionnaire and pre-developed data collection sheets by interviewing when the entire study participants were on 
treatment, then after the evaluation of patient by reviewing the record of TB treatment registration log book. A 
total of 281 study participants who fulfilled the inclusion criteria were included in the study. The data were entered 
and analyzed using SPSS 20 computer software. Result: A total of 227 (80.8%) patients had satisfactory treatment 
success rate in the study area. The odds of unfavorable treatment outcome was 81% (AOR: 0.19, 95% CI: 0.04 - 
0.87) less among patients 15-24 years of age compared to patients younger than 14 years of age. Females had 74% 
lower rates of successful treatment outcome (AOR: 0.26, 95% CI: 0.11- 0. 56) compared to male patients. However, 
patients who had lower distance than five kilometer for the health facilities had 3.87 times more likely to have 
favorable treatment outcome (AOR: 3.87, 95% CI: 1.83–8.29). HIV negative patients also had 20 times more 
likely to have favorable treatment outcome than HIV patients co-infected with TB (AOR: 20.35, 95%CI: 7.73-
53.63). Patients with bacteriologically confirmed pulmonary TB infection had 55% less likely to have favorable 
treatment outcome than clinically diagnosed TB cases (AOR: 0.45, 95% CI: 0.21-0.98). Conclusion and 
Recommendation: Finally this study showed that treatment success rate is less when compared to WHO stated 
target to be achieved in End TB Strategy. Therefore; it is important to focus on treatment adherence to improve 
favorable TB treatment outcome and consider DOTs service which is accessible to all clients.   
Keywords: Cure rate, treatment complete, favorable treatment outcome 
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INTRODUCTION 
Tuberculosis is caused by Mycobacterium Tuberculosis. It is transmitted from active cases to susceptible host 
through air when infectious person coughs or sneezes. Directly Observed Treatment of Short course (DOTs) is 
treatment strategy where the treatment is given under the direct supervision of a health worker. The treatment has 
now been standardized by putting patients into treatment regimen. The treatment of the patients in the program 
depend on patient category (new and retreated) (1, 2, 3, 5).  
The World Health Organization defines that the TB treatment outcome of the patient can be cured, treatment 
complete, lost to follow up ,died, treatment failure, moved to DR TB register and not evaluated; the success rate 
is measured by number of cured and treatment complete (1,2). 
The WHO has set a target for a treatment success rate of 90 % for all forms  of TB cases for 2016 in end TB 
strategic plan (5). The main objective of TB treatment is to cure the patient of TB, prevent death from active TB 
or its late effects; prevent relapse of TB; decrease transmission of TB to others and prevent the development of 
drug resistance TB (1, 2, 6). 
Different studies confirmed that comorbid with HIV, age, sex, residence area, distance from the treatment 
initiating center, and category of TB were  associated factors for unsuccessful treatment success rate (3). On the 
other way poor standardized TB treatment and patient adherence are the other major contributing factors for 
development of drug resistant TB in the community (4). Hence, assessing favor factors for poor treatment outcome 
is a great important for success of TB infection control program in Ethiopia. Tuberculosis is one of the leading 
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infectious causes of death globally. Approximately one third of the world’s population is infected with TB bacilli 
and at risk of developing active TB (9). According to WHO report 2015, worldwide, 9.6 million people are 
estimated to have fallen ill with TB in 2014: 5.4 million men, 3.2 million women, and 1.0 million children. Globally, 
12% of the 9.6 million new TB cases in 2014 were HIV-positive. TB is one of the world’s biggest threats, in 2014, 
TB killed 1.5 million people (1.1 million HIV-negative and 0.4 million HIV-positive). The toll comprised 890,000 
men, 480,000 women and 140, 000 children. TB now ranks alongside HIV as a leading cause of death worldwide 
(7). Also it is the leading cause of morbidity, the third cause of hospital admission, and the second cause of death 
in Ethiopia (8, 9).  According to WHO 2014 and 2015 report, the prevalence and incidence of all forms of TB are 
211 and 224 per 100,000 of the population, respectively. Ethiopia is one of the 22 high burden countries (7). 
According to Global TB report 2016, the incidence of TB is estimated to192/100K population, mortality rate 
(HIV negatives) is 26/100K populations, HIV co-infection rate among notified TB patients is 8% and TB is among 
top ten leading causes of inpatient mortality, also the drug resistant TB cases diagnosed was 2.7% among new 
cases and 14 % among previously TB cases (8). 
Drug-resistant TB is a growing challenge in response to TB. It is a man-made problem, largely as a result of 
individual or combination of factors related to management of drug supply, patient management, prescription of 
chemotherapy, and patient adherence that causes poor treatment success rate (10). 
Generally a good treatment outcome is an indicator for the quality of TB treatment provided by a health care 
system. Ideally, treatment outcome in all patients should be routinely monitored by the epidemiological 
surveillance system. However, most studies done on treatment outcome of TB patients shows age, sex ,knowledge 
of TB, family size, residence area, distance from the treatment indicating center and HIV Co-morbid  were the  
major contributing factors for poor treatment outcome. But most of these studies methods were only retrospective 
in Ethiopia. Hence, this study is needed to assess TB treatment outcome and its’ associated factors among TB 
patients treated under DOTs services prospectively. The finding of this study will help program implementers to 
improve the prevention and control of TB to achieve the global target and national set in End TB Strategy. And 
will have significant implications for strengthening favorable treatment outcome. In addition, it will also assist the 
regional TB control program coordinators, Adama Town Administration Health Office and health institutions in 
decision-making and planning for future time. To conceptualize this study socio demographic, patient factor and 
disease factors are framed as follows:- 
 
Figure 1: Conceptual framework of factors associated with TB treatment outcome. 
 
METHODS AND MATERIALS 
The study was conducted at Seventeen health facilities located in Adama Town which is found in central Oromia 
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Regional State, Eastern Ethiopia. An institutional based cross sectional study was conducted to assess TB treatment 
outcome   and its’ associated factors among TB patients treated under DOTs services. The sample size was 
determined by considering all Patients registered at the beginning of the study in 4 Hospital, 5 Health center and 
8 private clinics were included during the study period which was 281. 
A cross sectional institutional based data were collected using checklist by seventeen diploma /level IV nurses 
(focal person of TB assigned on TB clinic) after one day training on the objective of the study and data collection 
instrument and procedure. The socio demographic data which was not on TB unit register book (Educational status, 
occupation, distance from treatment center, income family size, religion) was collected from the study participant 
when they are on treatment and the record review was collected after the evaluation of the patient from TB unit 
register book.  Two supervisors were assigned for checking the completeness and consistency of the collected data 
and corrected the problem if occurs during the time of data collection. 
The data were entered into SPSS statistical software for analysis.  The distribution of the variables was 
explored and data cleaning was performed to identify outliers/inconsistence, errors and missing values. Descriptive 
statistics were computed to get summary values. Variables found statistically significant under bivariate analysis 
at a p value less than 0.25 were identified and the candidate variables were entered into multivariate logistic 
regression analysis to the see independent effect of the variable on the outcome variable and Odds ratio (OR) with 
95% confidence interval (CI) for each variables of interest was reported and p value less than 0.05 was considered 
as statistically significant for all the independent variables in the model. 
Definition of terms:  
DOT strategy: It is a new WHO protocol treatment regimen that put the patients under direct observation for the 
treatment of TB.     
Extra pulmonary TB: TB which involve other organ except the lungs. 
Pulmonary TB smear positive: A patient with at least one sputum specimens which are positive for AFB by 
microscopy. 
Bacteriological Confirmed: - A patient with at least one sputum specimens which are positive for AFB by 
microscopy or positive for AFB in Genxpert or culture test.  
Pulmonary TB- smear negative: A patient with symptoms suggestive of TB with at least two sputum specimens 
who were negative for AFB by microscopy and no improvement after tried by broad spectrum antibiotic   and with 
chest radiographic abnormalities consist with active PTB. 
Drug-resistant  TB  (DR-TB): It is  a  general  term  used  to  describe  a  strain  of  MTB that  is  resistant  to  
one  or  more  first line anti-TB  drugs. 
New case (N): A patient who has never had treatment for TB or has been on ant-TB treatment for less than four 
weeks. 
Relapse (R): A TB patient who have previously been treated for TB, were declared cured or treatment completed 
at the end of their most recent course of treatment, and are now diagnosed with a recurrent episode of TB. 
Treatment after Failure (F): Treatment after failure patients are those who have previously been treated for TB 
and whose sputum was positive at the end of five or later. 
Treatment after loss to follow-up (L): Patients who have previously been treated for TB for more than one month 
and stops treatment for more than eight weeks and were declared lost to follow-up at the end of their most recent 
course of treatment. 
Transfer in (T): A patient who started treatment in one reporting unit and transferred to another reporting unit to 
continue the treatment. 
Other previously treated patients (O):  Are those who have previously been treated for TB but whose outcome 
after their most recent course of treatment is unknown or undocumented. 
Treatment outcome: It is the result obtained after the initiation of the treatment of TB (cured, treatment complete, 
treatment failure, died, Lost to follow up, Not evaluated, Moved to MDT –TB Register). 
Treatment completed: A TB patient who completed treatment without evidence of failure BUT with no record 
to show that sputum smear or culture results in the last month of treatment and on at least one previous occasion 
were negative, either because tests were not done or because results are unavailable. 
Cured: A patient whose sputum smear or culture was positive at the beginning of the treatment but who was smear 
or culture-negative in the last month of treatment and on at least one previous occasion 
Treatment success: Defined as cure or A patient whose sputum smear or culture was positive at the beginning of 
the treatment but who was smear- or culture-negative in the last month of treatment and on at least one previous 
occasion plus treatment completion without confirmation by smear microscopy cured or complete treatment. 
Treatment failure (F): A patient whose sputum smear or culture is positive at 5 months or later during treatment 
or Patients found to harbor a drug-resistant (DR) strain at any point of time during the treatment, whether they are 
smear-negative or -positive. 
Died:  A TB patient who dies for any reason before starting or during the course of Treatment 
Lost to follow up: A TB patient who was treated at least for one month and whose treatment was interrupted for 
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two consecutive months or more and declared lost follow up in their recent treatment out-come. 
Not evaluated: A TB patient for whom no treatment outcome is assigned. This includes cases “transferred out” to 
another treatment unit as well as cases for whom the treatment outcome is unknown to the reporting unit.   
Moved to DR: A patient who has been diagnosed as having DR-TB as per the national guideline prior to being 
declared as’ Failure’ and is placed on MDR-TB TB treatment. 
Favorable treatment outcome: Cured and treatment completed. 
Unfavorable treatment outcome: Lost to follow up, Died, Treatment Failure, moved to DR, Not evaluated  
 
RESULTS  
Socio-Demographic Characteristics:- A total of 281 TB patients were registered at  Adama Town  in 6 public,10 
private and 1 NGO  health facilities among  which 157(55.9%) were males and 124 (44.1%) were females; and 
171(60.9%) were urban residents. More than one third (39.9%) of the patient were in the age group 25-34 with the 
mean age of 32.4 years.  Nearly half (48.8%) were daily laborers, more than half (59.4%) earn a monthly income 
of less than 600 ETB.  Nearly two-third (62.5%) of the respondents was at a distance of 5km or more from the 
Health facilities. About half (47.7%) respondents attended primary education. Concerning contact person 272 
(96.8%) of the respondents have contact person from which 256 (91.1%) of them register their family members as 
contact person (Table 1).  
Table 1: Socio demographic characteristics of TB patient who completed treatment at Adama Town health 
facilities, Central Oromia, Ethiopia from March 1st to December 31/2016. 
Socio demographic variables Characteristics    Frequency Percent             
Age >5yrs 4 1.4 
>14yrs 13 4.6 
15-24 102 36.3 
25-34 112 39.9 
≥35year 50 17.8 
Sex Male 157 55.9 
Female 124 44.1 
Residence  Urban 171 60.9 
Rural 110 39.1 
Occupation  Employed 31 19 
Merchant 68 24.2 
Farmer 34 12.1 
Daily laborer 137 48.8 
Others 11 1.1 
Income per month Less than 600 167 59.4 
600-1000 21 7.5 
1001-15000 29 10.3 
1501-2000 42 14.9 
2001-25000 12 4.3 
2501-3000 1 0.4 
3001-3500 5 1.8 
3501 and above 4 1.4 
Distance from treatment center   ≤ 5km 121 43 
    5km above 160 57 
Educational status No formal education 67 23.8 
Primary school 134 47.7 
Secondary & Above 80 28.5 
Family size  ≤ 5 79 32.2 
 Above 5 202 71.9 
Contact person HEW 7 2.5 
Health care worker 4 1.4 
Family member 256 91.1 
Self 5 1.8 
Category of TB: - In case of category of TB 121 (43.1%) were bacteriologically confirmed pulmonary TB, 86 
(30.6%) were clinically diagnosed Pulmonary Negative TB and the rest 74 (26.3%) were Extrapulmonary TB.  
HIV Status of the respondents: - From the total patients registered during the study period, 276 of were tested 
for HIV and greater part (86.8%) of the respondents were non-reactive for HIV.  Thirty five (12.4%) were TB/HIV 
co-infected.   
Treatment outcome:-The treatment outcome of TB patients was assessed. Accordingly, 90 (74.4%) were Cured, 
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137(48.8%) have completed the treatment, 4(1.4%) were treatment failure, 14(5%) were lost to follow up, 14 (5%) 
were died and 22 (7.8%) were not evaluated.  The overall treatment success rate was (80.8%).  Also when evaluated 
by category of TB, Bacteriologically confirmed TB patient 90(74%) were Cured, 13(10.8%) treatment their 
complete, 4(3.3%) were treatment Failure, 2(1.6%) were lost to follow up, 2 (1.6%) were died and 9 (3.3%) were 
not evaluated. From clinically diagnosed Pulmonary Negative 66(76.7%), complement their treatment, 7(8%) were 
lost follow up, 6(6.9%) were died, 6(6.9%) were not evaluated, and Extra pulmonary TB 57(77%) complement 
their treatment 5 (6.8%) were lost to follow up, 6 (5.4%) were died, 4(5.4%) were not evaluated. 
Factors associated with treatment outcome: - Logistic regression was employed to assess socio-demographic 
variables including age, sex, Residence, distance from treatment center, HIV status, Educational status, occupation, 
category of TB.   
In bivariate analysis, sex, distance from health from the treatment center, residence, knowledge of TB, category 
of TB and HIV status were associated with treatment outcome. Females had 67% lower rates of successful 
treatment outcome (COR: 0.33, 95% CI: 0.17, 0.65) compared to male patients. Patients from urban area were 
about 2 times more likely to have favorable treatment outcome than patients from rural area (COR: 1.90, 95%CI: 
1.05, 3.47). Patients who walked for less than five kilometers to the treatment center are 3.71 times more likely to 
have favorable treatment outcome than those who are far from the treatment center for more than five kilometers 
(COR: 3.71, 95% CI: 1.97-6..99). HIV negative patients were about 16 times more likely to have favorable 
treatment outcome than HIV patients co-infected with TB (COR: 15.71, 95%CI: 6.99, 35.29). Patients with 
bacteriologically confirmed pulmonary TB infection had 51% less likely to have favorable treatment outcome than 
clinically pulmonary TB and extra pulmonary TB (COR: 0.49, 95%CI: 0.26, 0.93).   
Table 2.   Bivariate Logistic regression analysis of factors associated with treatment outcome among TB patients 
at Adama Town health facilities, Central Oromia, Ethiopia from March 1st to December 30/ 2016 
Characteristics TB Treatment outcome COR 
95% CI 
 P-Value 
      Favorable  
      N (%) 
     Unfavorable  
         N (%) 
Age 
       < 15 
       15 – 24 
       25 - 34 
       ≥ 35 
 
12(70.6) 
90(88.2) 
87(77.7) 
38(76.0) 
 
5(29.4) 
12(11.8) 
25(22.3) 
12(24.0) 
 
1.00 
0.32(0.09,1.07) 
0.69(0.22,2.14) 
0.76(0.22,2.59) 
 
 
0.06 
0.52 
0.66 
Sex 
      Male 
      Female 
 
116(73.9) 
111(89.5) 
 
41(26.1) 
13(10.5) 
 
1.00 
0.33(0.17,0.65) 
 
 
0.001 
Residence 
      Urban 
      Rural 
 
145(84.8) 
82(74.5) 
 
26(15.2) 
28(25.5) 
 
1.00 
1.90(1.05,3.47) 
 
 
0.035 
Distance from HF 
      >5 Kms 
      ≤5 Kms 
 
84(69.4) 
143(89.4) 
 
37(30.6) 
17(10.6) 
 
3.71(1.97,6.99) 
1.00 
 
<0.001 
Education 
  No formal Education 
  Primary Education 
 Secondary & Above 
 
53(79.1) 
107(79.9) 
67(83.8) 
 
14(20.9) 
27(20.1) 
13(16.2) 
 
1.36(0.59,3.14) 
1.30(0.63,2.69) 
1.00 
 
0.47 
0.48 
Occupation 
       Employee 
        Merchant 
        Farmer  
        Daily laborer 
        Others*        
 
28 (93.3) 
54(85.7) 
22(78.6) 
114(76.0) 
9(90.0) 
 
2(6.7) 
9(14.3) 
6(21.4) 
36(24.0) 
1(10.0) 
 
1.00 
2.33(0.47,11.54) 
3.18(0.70,20.79) 
4.42(1.00,19.47) 
1.55(0.13,19.24) 
 
 
0.29 
0.12 
0.04 
0.73 
Category of TB 
         Bacteriological 
        Clinical  
 
105(86.6) 
122(76.2) 
 
16(13.2) 
38(23.8) 
 
0.49(0.26,0.93) 
1.00 
 
0.028 
HIV Status 
        Reactive 
        Non-reactive 
 
11(31.4) 
216(87.8) 
 
24(68.6) 
30(12.2) 
 
15.71(6.99,35.29) 
1.00 
 
<0.001 
* Students, Daily laborers 
In the multivariate analysis, the treatment outcome was varied with age, sex, distance from HF, category of 
TB and HIV status. The odds of unfavorable treatment outcome was 81% (AOR: 0.19, 95% CI: 0.04, 0.87) times 
less among patients 15-24 years of age compared to patients younger than 14 years of age. Females had 74% lower 
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rates of successful treatment outcome (AOR: 0.26, 95% CI: 0.11, 0. 56) compared to male patients. Patients were 
3.87 times  more likely to have favorable treatment  outcome if they had to walk for less than five kilometers to 
the treatment center  than those who are far from the treatment center for more than five kilometers (AOR: 3.87, 
95% CI: 1.83,8..29). HIV negative patients were about 20 times more likely to have favorable treatment outcome 
than HIV patients co-infected with TB (AOR: 20.35, 95%CI: 7.73, 53.63). Patients with bacteriologically 
confirmed pulmonary TB infection had 55% less likely to have favorable treatment outcome than clinically 
pulmonary TB and extra pulmonary TB (AOR: 0.45, 95%CI: 0.21, 0.98) (Table.4). 
Table 3. Multivariable logistic regression analysis of predictor variables of treatment outcome among TB patients 
at Adama Town Health facilities, Central Oromia, Ethiopia from March 1st to December 30/ 2016. 
Characteristics TB Treatment outcome AOR 
95% CI 
P-Value 
      Favorable  
      N (%) 
     Unfavorable  
         N (%) 
Age 
       < 15 
       15 – 24 
       25 - 34 
       ≥ 35 
 
12(70.6) 
90(88.2) 
87(77.7) 
38(76.0) 
 
5(29.4) 
12(11.8) 
25(22.3) 
12(24.0) 
 
1.00 
0.19(0.04,0.87)* 
0.50(0.12,2.03) 
0.83(0.19,3.59) 
 
 
0.032 
0.334 
0.800 
Sex 
      Male 
      Female 
 
116(73.9) 
111(89.5) 
 
41(26.1) 
13(10.5) 
 
1.00 
0.26(0.12,0.59)* 
 
 
0.001 
Distance from HF 
      >5 KMs 
      ≤5 KMs 
 
84(69.4) 
143(89.4) 
 
37(30.6) 
17(10.6) 
 
1.00 
3.87(1.83,8.29)* 
 
 
0.001 
Category of TB 
    Bacteriological 
    Clinical  
 
105(86.6) 
122(76.2) 
 
16(13.2) 
38(23.8) 
 
0.45(0.21,0.98)* 
1.00 
 
0.043 
HIV Status 
        Reactive 
        Non-reactive 
 
11(31.4) 
216(87.8) 
 
24(68.6) 
30(12.2) 
 
1.00 
20.35(7.73,53.63)* 
 
 
<0.001 
 
DISCUSSION 
Assessment of anti-tuberculosis treatment outcome as well as analysis of factors responsible for unfavorable 
treatment outcome is one of the major indicators for the evaluation of the performance of a national TB program. 
In facilities based cross sectional study, information on the treatment outcome of all types of TB patients across 
the study period were assessed in Adama Town health facilities.  This overall treatment success rate for all cases 
of tuberculosis in our study was 80.8%. This supports previous studies in Ethiopia with success rates of 85.6%, in 
North West Ethiopia (25), 85% success rate according to FMOH five years TBL, TB/HIV program analysis (23). 
This result showed a slight improvement when compared with retrospective cross-sectional survey done on 
TB treatment outcomes at Adama hospital medical college (AHMC) which showed 63.7% treatment success (31), 
at Gimbi Town with success rate of 74% (15) and at Gambella Hospital which trend of TB treatment outcome 
showed 63.4% (15). Other studies that in consistence with this study are the retrospective study that was conducted 
in Sagamu, Nigeria (13), prospective study done in South Africa which shows only 70% success fully treated (28) 
& in Brazil that shows unsuccessful was 24.6% (12). 
The retrospective study done in Afar Region in December 2016 shows that female patient were more likely 
to have successful treatment out come when compared to male patients (21). Also the other study conducted with 
in Specialty Health center and Jericho University College indicate male had high risk of poor treatment outcome 
than females (13). This finding is inconsistent with the finding of this study that showed females had lower rates 
of successful treatment outcome. This difference could be attributed to the cultural differences in the study societies 
(21). But it is similar with study conducted in 2013 at Debra Tabor Health Facilities that showed female had lower 
rate of successful treatment outcome (19). 
The result of this study indicated that HIV/AIDs has statistically significant impact on TB treatment outcome 
means from co-infected individuals have unfavorable treatment outcome whereas from non-reactive patients. This 
study is similar with study done in Cameroon Baptist convention health board tuberculosis treatment centers BBH 
(Banso Baptist Hospital) that showed better for treatment out come to be HIV negative while on treatment because 
HIV is the main reason for death and treatment failure (21).  
The other studies consistence with this result is the retrospective study done at Gimbi Town Health Facilities 
that reveals HIV status, treatment regimen and place of residence have significant impact on treatment outcome 
of TB patient (15). But the other retrospective study done from 2000 to 2011 in Tigray Region shows HIV status 
didn’t show any statically significant (22). 
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The patient near to the treatment center (less than 5km) had good treatment success when compared to those 
greater than 5km from the facility. It consistence with study done at Gondar university in July 2016 that shows 
successful treatment outcome was 66% lower among TB/HIV co-infected patient who have been residing outside 
living Gondar Town as compared those who have been living in Gondar (25). Also it agrees with national 
community care guide line which was papered in 2006 according to E.C.   
But the other retrospective and cross sectional study conducted on smear positive Tuberculosis cases in Tigray 
Region shows distance from the treatment center didn’t show any statistically significant (22). 
 This study revealed that Patients with bacteriologically confirmed pulmonary TB infection had 55% less 
likely to have favorable treatment outcome than clinically pulmonary and extra pulmonary. This finding agrees 
with the finding of Tigray Regional Health Bureau report (24), also it is consistence with the retrospective study 
done in March 2016 at Dabra Tabor, that shows to being smear negative PTB and EPTB had higher probability of 
being unsuccessful treatment outcome (19). Also the study conducted at Dilla University support this result that 
showed unsuccessful treatment outcome was also observed in PTB negative patients and EPTB compared to the 
PTB positive patients (24).   
 
CONCLUSION AND RECOMMENDATION 
The treatment outcome of all forms tuberculosis patient in Adama Town was unsatisfactory when compared with 
national target that sated in stop TB strategy (85%) in previously time and stated recently in End TB strategy 
(90%). The factors associated with this treatment outcome were Age, sex, distance from the treatment center, co-
infection with HIV and category of TB.  
This might be because of poor adherence patient with treatment regimen, poor lost to follow up tracing, poor 
practice of DOTs strategy and pill burden of the treatment. From unsatisfactory treatment there are 14 not evaluated 
cases this may slightly affect the result. On the other hand  the most   potentially infectious  or  (bacteriologically   
confirmed ) TB case the cure  (75%)  is very low  which is the serious  public health  problem that should  be 
addressed urgently.  
Finally as recommendation; female TB patient and those age between 15-24 should get additional  social 
support  to decrease the lost follow up  rate by  health  facilities TB focal  person and the  management commute 
and  strengthen  early tracing with catchment area health extension workers. And all health facilities TB focal 
person and management committee should arrange HIV exposed TB patient to enroll in chronic HIV care or refer 
to chronic HIV care center. As organization; being with Adama Town Administration Health Office; health 
facilities should decentralize DOTs service to the lower health facility to make convenient for the patient those 
should go greater than five Kilo meter for treatment. And also Adama Town Administration Health Office should 
arrange feedback mechanism for TB patient that started treatment in the facility and registered on log book, then 
referred to other health facility to exchange patient evaluation among their TB focal person and others.  
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